The store will not work correctly when cookies are disabled.
1-(2-(1H-indol-3-yl)ethyl)-3-(3,4-dichlorophenyl)urea
ID: ALA4248460
Cas Number: 32539-39-2
PubChem CID: 2195029
Max Phase: Preclinical
Molecular Formula: C17H15Cl2N3O
Molecular Weight: 348.23
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(NCCc1c[nH]c2ccccc12)Nc1ccc(Cl)c(Cl)c1
Standard InChI: InChI=1S/C17H15Cl2N3O/c18-14-6-5-12(9-15(14)19)22-17(23)20-8-7-11-10-21-16-4-2-1-3-13(11)16/h1-6,9-10,21H,7-8H2,(H2,20,22,23)
Standard InChI Key: JAWNRLZTUAFYAS-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 25 0 0 0 0 0 0 0 0999 V2000
8.2076 -11.1228 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2065 -11.9424 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9145 -12.3513 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6242 -11.9419 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6214 -11.1192 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9128 -10.7140 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4985 -12.3504 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.7911 -11.9413 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0830 -12.3493 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.7917 -11.1241 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.3757 -11.9401 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6676 -12.3482 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9842 -11.9000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9465 -11.0817 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1581 -10.8663 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.2210 -12.1870 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7120 -11.5521 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9096 -11.6760 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6151 -12.4344 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1291 -13.0693 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9297 -12.9421 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3275 -10.7080 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
10.3326 -12.3494 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
2 7 1 0
7 8 1 0
8 9 1 0
8 10 2 0
9 11 1 0
11 12 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 17 1 0
16 13 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
5 22 1 0
4 23 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 348.23 | Molecular Weight (Monoisotopic): 347.0592 | AlogP: 4.84 | #Rotatable Bonds: 4 |
Polar Surface Area: 56.92 | Molecular Species: NEUTRAL | HBA: 1 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 13.29 | CX Basic pKa: ┄ | CX LogP: 4.42 | CX LogD: 4.42 |
Aromatic Rings: 3 | Heavy Atoms: 23 | QED Weighted: 0.62 | Np Likeness Score: -1.55 |
References
1. Anglin J, Zavareh RB, Sander PN, Haldar D, Mullarky E, Cantley LC, Kimmelman AC, Lyssiotis CA, Lairson LL.. (2018) Discovery and optimization of aspartate aminotransferase 1 inhibitors to target redox balance in pancreatic ductal adenocarcinoma., 28 (16): [PMID:29731362] [10.1016/j.bmcl.2018.04.061] |
2. Minrovic BM, Hubble VB, Barker WT, Jania LA, Melander RJ, Koller BH, Melander C.. (2019) Second-Generation Tryptamine Derivatives Potently Sensitize Colistin Resistant Bacteria to Colistin., 10 (5): [PMID:31098007] [10.1021/acsmedchemlett.9b00135] |